RG

Rishi Ganju

Active Director Director DIN 09313050
DIN 09313050 First appointment Sep 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Sep 2021
Shareholding value Locked Premium profile

About Rishi Ganju

Rishi Ganju has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Atrimed Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09313050
Primary Designation Director
First Appointment 09 Sep 2021
Oldest Company Age 23 yrs

Current companies

Company Designation Appointment Founded Status
Director 09 Sep 2021 2003 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Atrimed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rishi Ganju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rishi Ganju

Rishi Ganju has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Atrimed Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Rishi Ganju is associated with 1 company as Director.

Rishi Ganju has expertise in General Business.

Rishi Ganju has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available